Fiche centre
GSK Investigational Site
Barcelona — Spain
Essais liés3clinical trials
VilleBarcelonalocalisation
PaysSpainlocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT01772199
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| GSK4527226 | Alzheimer | Phase 2 | NCT06079190 | PROGRESS-AD — Efficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's Disease | TERMINATED |
| Belimumab (GSK1550188) | Lupus | Phase 4 | NCT06411249 | A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE) | ACTIVE_NOT_RECRUITING |
| GSK239512 | SEP | Phase 2 | NCT01772199 | Study to Assess Whether GSK239512 Can Remyelinate Lesions in Subjects With Relapsing Remitting Multiple Sclerosis | COMPLETED |